Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20200616047799N1
IRCT20200616047799N1
Completed
Phase 1

Comparison of serum inflammatory mediators levels in patients affected by COVID-19 with and without photobiomodulation (PBM)

Shahid Beheshti University of Medical Sciences0 sites40 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 1
Status
Completed
Enrollment
40
OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
15 years to no limit (—)
Sex
All

Inclusion Criteria

  • •COVID\-19 Pneumonia
  • •Written consent
  • •Older than 15 years

Exclusion Criteria

  • •Intubated patients
  • •Skin hypersensitivities or its history
  • •Inflammation of the site of PBM implementation

Investigators

Similar Trials

Not yet recruiting
Not Applicable
Assessment of severity of chest injury in geriatric patient with inflammatory marker and chest trauma scoreHealth Condition 1: S224- Multiple fractures of ribs
CTRI/2022/07/044314IMS BHU DEPT OF ANAESTHESIOLOGY
Not yet recruiting
Phase 4
Comparison of inflammation markers and bone loss in fluid around different dental implants over time
CTRI/2024/03/063828Dr.Paulina
Not yet recruiting
Phase 2
A Comparative Study of Inflammation in Gum Fluid After Using Two Dental Treatments for Severe Tooth Pai
CTRI/2024/07/070985Dr Ranjana Hanumant Deshmukh
Recruiting
Not Applicable
To determine effect of Different teeth capping material on gingival health.
CTRI/2022/09/046085Mohan Mahajan
Not yet recruiting
Not Applicable
DH and Ferritin levels in Diabetes Mellitus.Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: E086- Diabetes mellitus due to underlying condition with other specified complications
CTRI/2021/03/031970Self